Physician profile
Peter Airel
NPI 1538222047
$400.19
in general payments reported to CMS, 2019-2025
10 companies · $19.45 in 2025
The $19.45 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $33.44 · 2021: $15.19 · 2022: $217 · 2023: $99.77 · 2024: $15.61 · 2025: $19.45.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $135.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $134.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $133.57 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $84.71 | 2019-2023 | Trulance |
| Janssen Biotech, INC. | $47.59 | 2022-2023 | Stelara |
| Amgen INC. | $31.26 | 2023 | Amjevita, Avsola |
| Intercept Pharmaceuticals, INC. | $20.31 | 2023 | Ocaliva |
| Ardelyx, INC. | $19.45 | 2025 | Ibsrela |
| Genzyme Corporation | $18.08 | 2022 | |
| Boston Scientific Corporation | $15.61 | 2024 | Watchman Access System |
| Takeda Pharmaceuticals U.S.A., INC. | $15.12 | 2022 | |
| Capsovision, INC. | $14.49 | 2023 | Capsocam Plus |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Airel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.